off label tirzepatide Mounjaro for Weight Loss: Off-Label Use for Weight Management Does Tirzepatide Help With Inflammation?

Initially developed for the treatment of obesity, semaglutide has shown potential for improving energy levels, mood, and appetite control

Research indicates that a meaningful percentage of weight lost on GLP-1 receptor agonists can come from lean tissue rather than adipose tissue, particularly without resistance guidance, adequate protein intake, or physician-directed dose titration

Instead, you can order injectable B12 and do it yourself

Do I have to sign a long contract

Just as we use medications to treat cancer or heart disease, we shouldnt be afraid to consider medications to treat obesity, she adds

Research has identified these alarming vision-related risks associated with GLP-1 medications: Sudden irreversible vision loss: NAION strikes without warning, often discovered upon waking, causing blurry or dim vision that progresses to immediate and permanent partial or complete blindness in the affected eye with no possibility of restoration Elevated risk across multiple studies: Beyond the Harvard findings showing 4-7 fold increased risk, a University of Southern Denmark study examining over 424,000 patients found weekly semaglutide users faced 2.19 times higher NAION risk European regulatory recognition: In June 2025, the European Medicines Agency officially recognized NAION as a possible side effect of semaglutide medications, marking formal acknowledgment by international regulators Complete absence of treatment options: Medical science currently offers no cure, no effective treatment, and no way to reverse NAION-related vision damage, leaving patients with permanent disability The permanent and irreversible nature of NAION-related optic nerve damage distinguishes these injuries from other complications that may resolve after discontinuing medication